Athira Pharma
ATHA
ATHA
105 hedge funds and large institutions have $354M invested in Athira Pharma in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 106 → 105 (-1)
26% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 35
Holders
105
Holding in Top 10
1
Calls
$41.5M
Puts
$19.2M
Top Buyers
| 1 | +$9.36M | |
| 2 | +$3.14M | |
| 3 | +$2.67M | |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$2.53M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.11M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$3.39M | |
| 3 | -$2.29M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$1.82M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$1.52M |